vs

Side-by-side financial comparison of Adaptive Biotechnologies Corp (ADPT) and SYNCHRONOSS TECHNOLOGIES INC (SNCR). Click either name above to swap in a different company.

Adaptive Biotechnologies Corp is the larger business by last-quarter revenue ($70.9M vs $42.0M, roughly 1.7× SYNCHRONOSS TECHNOLOGIES INC). SYNCHRONOSS TECHNOLOGIES INC runs the higher net margin — 13.8% vs 4.7%, a 9.1% gap on every dollar of revenue. On growth, Adaptive Biotechnologies Corp posted the faster year-over-year revenue change (35.1% vs -2.2%). Over the past eight quarters, Adaptive Biotechnologies Corp's revenue compounded faster (28.1% CAGR vs 0.7%).

ExpreS2ion Biotechnologies is a Danish biotechnology company specialised in the development of new vaccines and immunotherapy products based in Hørsholm, Denmark and listed on the Nasdaq First North Growth Market Sweden.

Synchronoss Technologies Inc develops cloud-based digital transformation, subscriber management and messaging solutions for global telecom operators and enterprise clients. Its core offerings support connectivity onboarding, IoT service enablement, with key markets spanning North America, Europe and Asia-Pacific.

ADPT vs SNCR — Head-to-Head

Bigger by revenue
ADPT
ADPT
1.7× larger
ADPT
$70.9M
$42.0M
SNCR
Growing faster (revenue YoY)
ADPT
ADPT
+37.4% gap
ADPT
35.1%
-2.2%
SNCR
Higher net margin
SNCR
SNCR
9.1% more per $
SNCR
13.8%
4.7%
ADPT
Faster 2-yr revenue CAGR
ADPT
ADPT
Annualised
ADPT
28.1%
0.7%
SNCR

Income Statement — Q1 FY2026 vs Q3 FY2025

Metric
ADPT
ADPT
SNCR
SNCR
Revenue
$70.9M
$42.0M
Net Profit
$3.4M
$5.8M
Gross Margin
73.6%
79.4%
Operating Margin
-27.1%
14.0%
Net Margin
4.7%
13.8%
Revenue YoY
35.1%
-2.2%
Net Profit YoY
201.7%
EPS (diluted)
$0.51

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ADPT
ADPT
SNCR
SNCR
Q1 26
$70.9M
Q4 25
$71.7M
Q3 25
$94.0M
$42.0M
Q2 25
$58.9M
$42.5M
Q1 25
$52.4M
$42.2M
Q4 24
$47.5M
$44.2M
Q3 24
$46.4M
$43.0M
Q2 24
$43.2M
$43.5M
Net Profit
ADPT
ADPT
SNCR
SNCR
Q1 26
$3.4M
Q4 25
$-13.6M
Q3 25
$9.5M
$5.8M
Q2 25
$-25.6M
$-19.6M
Q1 25
$-29.9M
$-3.8M
Q4 24
$-33.7M
$7.9M
Q3 24
$-32.1M
$-5.7M
Q2 24
$-46.2M
$-494.0K
Gross Margin
ADPT
ADPT
SNCR
SNCR
Q1 26
73.6%
Q4 25
74.6%
Q3 25
80.7%
79.4%
Q2 25
69.4%
79.0%
Q1 25
67.6%
79.4%
Q4 24
62.0%
78.6%
Q3 24
64.1%
79.1%
Q2 24
55.3%
76.1%
Operating Margin
ADPT
ADPT
SNCR
SNCR
Q1 26
-27.1%
Q4 25
-17.8%
Q3 25
10.9%
14.0%
Q2 25
-42.5%
16.1%
Q1 25
-56.4%
19.5%
Q4 24
-71.3%
16.5%
Q3 24
-70.3%
12.8%
Q2 24
-109.6%
9.9%
Net Margin
ADPT
ADPT
SNCR
SNCR
Q1 26
4.7%
Q4 25
-18.9%
Q3 25
10.2%
13.8%
Q2 25
-43.5%
-46.1%
Q1 25
-56.9%
-9.0%
Q4 24
-71.0%
17.8%
Q3 24
-69.1%
-13.3%
Q2 24
-107.0%
-1.1%
EPS (diluted)
ADPT
ADPT
SNCR
SNCR
Q1 26
Q4 25
$-0.08
Q3 25
$0.06
$0.51
Q2 25
$-0.17
$-1.87
Q1 25
$-0.20
$-0.37
Q4 24
$-0.22
$0.75
Q3 24
$-0.22
$-0.56
Q2 24
$-0.31
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ADPT
ADPT
SNCR
SNCR
Cash + ST InvestmentsLiquidity on hand
$77.6M
$34.8M
Total DebtLower is stronger
$163.2M
Stockholders' EquityBook value
$55.4M
Total Assets
$505.9M
$278.2M
Debt / EquityLower = less leverage
2.95×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ADPT
ADPT
SNCR
SNCR
Q1 26
$77.6M
Q4 25
$70.5M
Q3 25
$55.0M
$34.8M
Q2 25
$43.2M
$24.6M
Q1 25
$50.6M
$29.1M
Q4 24
$47.9M
$33.4M
Q3 24
$38.1M
$25.2M
Q2 24
$59.8M
$23.6M
Total Debt
ADPT
ADPT
SNCR
SNCR
Q1 26
Q4 25
Q3 25
$163.2M
Q2 25
$186.2M
Q1 25
$187.0M
Q4 24
$186.7M
Q3 24
$186.4M
Q2 24
$186.2M
Stockholders' Equity
ADPT
ADPT
SNCR
SNCR
Q1 26
Q4 25
$218.8M
Q3 25
$204.4M
$55.4M
Q2 25
$179.7M
$49.4M
Q1 25
$190.4M
$35.4M
Q4 24
$202.7M
$29.8M
Q3 24
$223.8M
$35.3M
Q2 24
$241.6M
$30.6M
Total Assets
ADPT
ADPT
SNCR
SNCR
Q1 26
$505.9M
Q4 25
$512.7M
Q3 25
$490.6M
$278.2M
Q2 25
$496.6M
$291.4M
Q1 25
$510.9M
$293.3M
Q4 24
$539.4M
$293.8M
Q3 24
$558.5M
$299.7M
Q2 24
$584.9M
$295.7M
Debt / Equity
ADPT
ADPT
SNCR
SNCR
Q1 26
Q4 25
Q3 25
2.95×
Q2 25
3.77×
Q1 25
5.28×
Q4 24
6.27×
Q3 24
5.28×
Q2 24
6.08×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ADPT
ADPT
SNCR
SNCR
Operating Cash FlowLast quarter
$39.4M
Free Cash FlowOCF − Capex
$39.0M
FCF MarginFCF / Revenue
92.9%
Capex IntensityCapex / Revenue
0.9%
Cash ConversionOCF / Net Profit
6.77×
TTM Free Cash FlowTrailing 4 quarters
$53.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ADPT
ADPT
SNCR
SNCR
Q1 26
Q4 25
$2.1M
Q3 25
$-7.1M
$39.4M
Q2 25
$-12.4M
$2.3M
Q1 25
$-28.5M
$293.0K
Q4 24
$-12.5M
$13.1M
Q3 24
$-27.1M
$3.4M
Q2 24
$-17.3M
$11.3M
Free Cash Flow
ADPT
ADPT
SNCR
SNCR
Q1 26
Q4 25
$1.4M
Q3 25
$-7.5M
$39.0M
Q2 25
$-13.1M
$2.0M
Q1 25
$-29.7M
$-31.0K
Q4 24
$-12.6M
$12.2M
Q3 24
$-27.4M
$3.2M
Q2 24
$-19.0M
$10.9M
FCF Margin
ADPT
ADPT
SNCR
SNCR
Q1 26
Q4 25
2.0%
Q3 25
-8.0%
92.9%
Q2 25
-22.2%
4.6%
Q1 25
-56.7%
-0.1%
Q4 24
-26.5%
27.6%
Q3 24
-59.0%
7.5%
Q2 24
-44.1%
25.2%
Capex Intensity
ADPT
ADPT
SNCR
SNCR
Q1 26
Q4 25
0.9%
Q3 25
0.4%
0.9%
Q2 25
1.1%
0.8%
Q1 25
2.4%
0.8%
Q4 24
0.2%
1.9%
Q3 24
0.7%
0.3%
Q2 24
4.0%
0.9%
Cash Conversion
ADPT
ADPT
SNCR
SNCR
Q1 26
Q4 25
Q3 25
-0.75×
6.77×
Q2 25
Q1 25
Q4 24
1.66×
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ADPT
ADPT

Segment breakdown not available.

SNCR
SNCR

Subscription Services$39.4M94%
Professional Services$2.6M6%

Related Comparisons